Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Raabe
P018 Afatinib Named Patient Use Program in Advanced NSCLC With Progression on Prior Therapy: Experience From Asian Centers
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-11 Named Patient Use Program for Afatinib in Advanced NSCLC With Progression on Prior Therapy: Experience From Asian Centers
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Afatinib in Advanced NSCLC: A Profile of Its Use
Drugs and Therapy Perspectives
Pharmacology
P1.04-09 Immunomodulatory Effects of Afatinib and Pembrolizumab in EGFR-Mutant NSCLC With Progression on Prior EGFR-TKI
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers
Oncologist
Cancer Research
Medicine
Oncology
Osimertinib as First-Line Therapy in Advanced NSCLC: A Profile of Its Use
Drugs and Therapy Perspectives
Pharmacology
P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients With EGFR Mutation-Positive Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Real-World Experience of Afatinib as a First-Line Therapy for Advanced EGFR Mutation-Positive Lung Adenocarcinoma
Oncotarget
Oncology
OA03 Afatinib Followed by Osimertinib in Real-World Patients With EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
